Extracellular Vesicles to Predict Outcomes After Transcatheter Aortic Valve Implantation - a Prospective, Multicenter Cohort Study.
暂无分享,去创建一个
E. van der Pol | J. Kochman | Z. Huczek | M. Jemielity | A. Gąsecka | J. Hiczkiewicz | J. Budzianowski | Wojciech Faron | M. Grygier | T. Urbanowicz | A. Olasińska-Wiśniewska | R. Nieuwland | Olaf Domaszk | R. Wilimski | Bartosz Rymuza | Szymon Jędrzejczyk | Marcin Grabowski | Mariusz Kuśmierczyk | Michał Łomiak | Katarzyna Pieniak | Magdalena Chudzik | Krzysztof J Filipiak
[1] P. Teirstein,et al. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. , 2023, Journal of the American College of Cardiology.
[2] Jihe Li,et al. Procoagulant effect of extracellular vesicles in patients after transcatheter aortic valve replacement or transcatheter aortic valve replacement with percutaneous coronary intervention , 2023, Journal of Thrombosis and Thrombolysis.
[3] Jennifer C. Jones,et al. A compendium of single extracellular vesicle flow cytometry , 2023, Journal of extracellular vesicles.
[4] Anas M. Saad,et al. Association between haematological parameters and outcomes following transcatheter aortic valve implantation at mid-term follow-up , 2022, Open Heart.
[5] A. Hendrix,et al. Removal of platelets from blood plasma to improve the quality of extracellular vesicle research , 2022, Journal of thrombosis and haemostasis : JTH.
[6] G. Nickenig,et al. Transverse aortic constriction-induced heart failure leads to increased levels of circulating microparticles. , 2021, International journal of cardiology.
[7] T. V. van Leeuwen,et al. EDTA stabilizes the concentration of platelet-derived extracellular vesicles during blood collection and handling , 2021, Platelets.
[8] C. Dubois,et al. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence , 2021, International journal of molecular sciences.
[9] Seung‐Jung Park,et al. Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation. , 2021, The American journal of cardiology.
[10] T. Kawaguchi,et al. Long-Term Prognostic Value of the Society of Thoracic Surgery Risk Score in Patients Undergoing Transcatheter Aortic Valve Implantation (From the OCEAN-TAVI Registry). , 2021, The American journal of cardiology.
[11] A. Harky,et al. TAVI and the future of aortic valve replacement , 2019, Journal of cardiac surgery.
[12] T. V. van Leeuwen,et al. Refractive index to evaluate staining specificity of extracellular vesicles by flow cytometry , 2019, Journal of extracellular vesicles.
[13] Elmar L. Gool,et al. Absolute sizing and label-free identification of extracellular vesicles by flow cytometry. , 2018, Nanomedicine : nanotechnology, biology, and medicine.
[14] Jeroen J. Bax,et al. Guía ESC/EACTS 2017 sobre el tratamiento de las valvulopatías , 2018 .
[15] H. Figulla,et al. Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI) , 2016, Heart and Vessels.
[16] J. Krieger,et al. Endothelial, platelet, and macrophage microparticle levels do not change acutely following transcatheter aortic valve replacement , 2016, Journal of Negative Results in BioMedicine.
[17] C. Otto,et al. Calcific aortic stenosis , 2016, Nature Reviews Disease Primers.
[18] K. Segawa,et al. An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure. , 2015, Trends in cell biology.
[19] J. Heemskerk,et al. Platelet‐based coagulation: different populations, different functions , 2013, Journal of thrombosis and haemostasis : JTH.
[20] X. Wehrens,et al. Transverse aortic constriction in mice. , 2010, Journal of visualized experiments : JoVE.
[21] Alec Vahanian,et al. Valvular heart disease in the community: a European experience. , 2007, Current problems in cardiology.
[22] David W. Banner,et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor , 1996, Nature.